Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
CLOFARABINE
Clolar
Leukemia
CLO05908NAEudraCT: 2015-001172-21Tabulated Results
CLOFARABINE
Clolar®
Relapsed/refractory acute lymphoblastic leukaemia
CLO08708 (OBS12879)NASummary
CLOFARABINE
Clolar
Leukemia
CLO08808NAEudraCT: 2015-001173-41Tabulated Results
CLOFARABINE
Clolar
Leukemia
CLO212*NANCT00042341Summary
CLOFARABINE
Clolar
Leukemia
CLO21800205NANCT00315705Tabulated Results
CLOFARABINE
Clolar
Leukemia
CLO222*NANCT00042354Summary
CLOFARABINE
Clolar
Leukemia
CLO24300606CLASSIC IINCT00373529Tabulated Results
CLOFARABINE
Clolar
Leukemia
CLO34100405CLASSIC INCT00317642Tabulated Results
CLOFARABINE
Clolar®
Relapse/refractory acute lymphoblastic leukemia
CLOFAL06952 (OBS15637)NASummary
CLOFARABINE
Clolar®
Relapsed/refractory acute lymphoblastic leukemia
CLOFAL07263 (OBS15639)NASummary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted